The finding that GPR55 is essentially a lymphocyte marker in lymph nodes can be used to complement biomarkers that identify CC tumor cells either by performing combined marker analysis or by calculating a marker ratio and using this ratio to allocate the patients into a positive or negative group. This evidence concerns the gene GPR55 and cholangiocarcinoma.